NCT07029256 Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
| NCT ID | NCT07029256 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Bladder Urothelial Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-07-26 |
| Primary Completion | 2030-07-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-07-26 with a primary completion date of 2030-07-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).
Eligibility Criteria
Inclusion Criteria: * Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder * Prior abdominal imaging Exclusion Criteria: * History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)
Contact & Investigator
Vidit Sharma, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic in Rochester
Frequently Asked Questions
Who can join the NCT07029256 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Urothelial Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07029256 currently recruiting?
Yes, NCT07029256 is actively recruiting participants. Contact the research team at biffert.hosanna@mayo.edu for enrollment information.
Where is the NCT07029256 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07029256 clinical trial?
NCT07029256 is sponsored by Mayo Clinic. The principal investigator is Vidit Sharma, MD at Mayo Clinic in Rochester. The trial plans to enroll 100 participants.